126 related articles for article (PubMed ID: 6882253)
1. Eye findings in patients with phenylketonuria.
Zwaan J
Arch Ophthalmol; 1983 Aug; 101(8):1236-7. PubMed ID: 6882253
[TBL] [Abstract][Full Text] [Related]
2. Phenylketonuria does not cause cataracts.
Pitt DB; O'Day J
Eur J Pediatr; 1991 Jul; 150(9):661-4. PubMed ID: 1915521
[TBL] [Abstract][Full Text] [Related]
3. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
Gualtieri CT; Lefler WH; Guimond M; Staye JI
Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of classical phenylketonuria in mentally retarded individuals in Iran.
Ghiasvand NM; Aledavood A; Ghiasvand R; Seyedin Borojeny F; Aledavood AR; Seyed S; Miner W; Saeb Taheri GR
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S283-7. PubMed ID: 19768570
[TBL] [Abstract][Full Text] [Related]
5. A Chinese family with phenylketonuria and maternal phenylketonuria detected by family screening.
Hsiao KJ; Chen CH; Chiu PC; Huang SC; Wuu KD
Eur J Pediatr; 1986 Oct; 145(5):409-12. PubMed ID: 3792388
[TBL] [Abstract][Full Text] [Related]
6. The incidence of phenylketonuria in Thailand.
Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P
J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457
[TBL] [Abstract][Full Text] [Related]
7. Three cases of untreated classical PKU: a report on cataracts and brain calcification.
Kawashima H; Kawano M; Masaki A; Sato T
Am J Med Genet; 1988 Jan; 29(1):89-93. PubMed ID: 3344778
[TBL] [Abstract][Full Text] [Related]
8. Aminoaciduria and mental retardation. II. Phenylpyruvic oligophrenia, phenylketonuria (PKU).
ZELLWEGER H
J Iowa State Med Soc; 1961 Aug; 51():536-40. PubMed ID: 13788179
[No Abstract] [Full Text] [Related]
9. Can untreated PKU patients escape from intellectual disability? A systematic review.
van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
[TBL] [Abstract][Full Text] [Related]
10. Severe mental retardation in five siblings due to maternal phenyketonuria.
Blomquist HK; Gustavson KH; Holmgren G
Neuropediatrics; 1980 Aug; 11(3):256-61. PubMed ID: 6893484
[TBL] [Abstract][Full Text] [Related]
11. The natural history of untreated phenylketonuria over 20 years.
Pitt DB; Danks DM
J Paediatr Child Health; 1991 Jun; 27(3):189-90. PubMed ID: 1909536
[TBL] [Abstract][Full Text] [Related]
12. Biochemical screening for inherited metabolic disorders in the mentally retarded.
Henderson HE; Goodman R; Schram J; Diamond E; Daneel A
S Afr Med J; 1981 Nov; 60(19):731-3. PubMed ID: 6795726
[TBL] [Abstract][Full Text] [Related]
13. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
[TBL] [Abstract][Full Text] [Related]
14. Phenylketonuria and scleroderma.
Lasser AE; Schultz BC; Beaff D; Bielinski S; Kirschenbaum B
Arch Dermatol; 1978 Aug; 114(8):1215-7. PubMed ID: 677922
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmological findings of phenylketonuria: a survey of 14 cases.
Cotticelli L; Costagliola C; Rinaldi E; DiMeo A; Sartorio R; Vajro P; Andria G
J Pediatr Ophthalmol Strabismus; 1985; 22(2):78-9. PubMed ID: 3989646
[No Abstract] [Full Text] [Related]
16. Patient with Phenylketonuria and Intellectual Disability-Problem Not Always Caused Exclusively by Insufficient Metabolic Control (Coexistence of PKU and Alazami Syndrome).
Patalan M; Leśniak A; Bernatowicz K; Romanowska H; Krzywińska-Zdeb E; Walczak M; Giżewska M
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270292
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of phenylketonuria and some other metabolic disorders among mentally retarded patients in Finland.
Palo J
Acta Neurol Scand; 1967; 43(5):573-9. PubMed ID: 6083364
[No Abstract] [Full Text] [Related]
18. Urinary screening for abnormalities of amino acid or mucopolysaccharide metabolism in patients in a hospital for the mentally handicapped in Wessex.
Walker V; Smythe PJ; Cook NJ; Ball NA; Veall RM; Whiteman P
J Ment Defic Res; 1983 Jun; 27 (Pt 2)():105-14. PubMed ID: 6225873
[TBL] [Abstract][Full Text] [Related]
19. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
Bouchlariotou S; Tsikouras P; Maroulis G
J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
[TBL] [Abstract][Full Text] [Related]
20. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
